MOBILion Systems is enabling advancements in disease diagnosis and treatment by commercializing instruments that improve drug, and biomarker discovery. Enhancing the study of the complement to genomics provides a better understanding of disease and drug target mechanisms and paves the way for earlier disease detection, more accurate diagnostics, improved treatment options for individual patients and reduced healthcare costs.